Best Biotech Companies To Watch For 2015

Best Biotech Companies To Watch For 2015: BIND Therapeutics Inc (BIND)

BIND Therapeutics, Inc., incorporated on May 19, 2006, is a clinical-stage nanomedicine platform company developing Accurins, its targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Its drug candidate, BIND-014, is in Phase II clinical trials for non-small cell lung cancer, or NSCLC, and metastatic castrate-resistant prostate cancer (mCRPC).

Accurins represent the evolution of targeted therapies and nanomedicine. Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload. The four components include Targeting ligands, St ealth and protective layer, Controlled-release polymer matrix and Therapeutic payload. The Company focuses to use its medicinal nanoengineering platform to develop Accurins in several therapeutic areas, with an initial focus on the treatment of various types of cancer. In addition, the Company entered into collaboration agreements with several biopharmaceutical companies to develop and commercialize Accurins that are based on its collaborators therapeutic payloads. The Companys programs include BIND-014, solid tumor accurin and hematologic cancer accurin.

Advisors' Opinion:

• [By Garrett Cook]

  BIND Therapeutics (NASDAQ: BIND) was down, falling 10.56 percent to $11.52 after the company reported the closing of collaboration deal with Amgen (NASDAQ: AMGN).

• [By John Udovich]

  The biotech sector has been pretty exciting this yearwith small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) an! d TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investorswhile Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have justset term sheets for their upcoming IPOs. Just consider all of the following recent news:

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-biotech-companies-to-watch-for-2015.html